HIV/Aids

15 August 2007

OD risk with kids' HIV med

Doctors need to be careful when using the anti-HIV drug Kaletra in children, says an Abbott Laboratories letter posted on the US Food and Drug Administration's Web site.

0
Doctors need to be careful when using the anti-HIV drug Kaletra in children, says an Abbott Laboratories letter posted on the US Food and Drug Administration's Web site.

The drug maker wrote the letter after the accidental overdose death of an infant born with HIV, who died nine days after receiving a 6.5 millilitre dose of Kaletra, the Associated Press reported.

In the letter, Abbott reminds doctors that children should receive less than a 5 millilitre dose of Kaletra oral solution.

"Special attention must be paid to accurate calculation of the dose, transcription of the medication order, dispensing information and dosing instructions to minimise the risk of medication," the letter states.

Kaletra prevents reproduction of HIV, the virus that causes Aids. – (HealthDayNews)

Read more:
HIV/Aids Centre

August 2007

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.

Ask the Expert

HIV/Aids expert

Dr Sindisiwe van Zyl qualified at the University of Pretoria in 2005. She is a patients' rights activist and loves using social media to teach about HIV. She is in private practice in Johannesburg.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules